Pulmonary Hypertension
Pulmonary hypertension is a type of high blood pressure that impacts the arteries in lungs and the right side of heart. In one type of pulmonary hypertension, modest arteries in lungs, called pulmonary arterioles, and capillaries become narrowed, blocked or destroyed. This makes it harder for blood to flow through lungs, and raises pressure inside the arteries of lungs. As the pressure builds, heart's lower right chamber (right ventricle) must work harder to direct blood through lungs, in the end causing heart muscle to debilitates and fail. Few categories of pulmonary hypertension are serious conditions that become progressively worse and sometimes become fatal. Pulmonary hypertension can lead to a number of COPD complications such as blood clots in the lungs, sickle cell disease and sleep apnea. Although a few kinds of pulmonary hypertension are not curable, treatment can help decrease symptoms and enhance quality of life. Pulmonary Conferences concentrates on the impact of pulmonary hypertension.
- Pulmonary arterial hypertension
- Pulmonary Embolism
- Pulmonary Venous Hypertension
- Molecular pathology
- Acute Exacerbation
Related Conference of Pulmonary Hypertension
15th International Conference on Pulmonary & Respiratory Medicine
4th International Conference on Tuberculosis, Lung Health and Respiratory Diseases
Pulmonary Hypertension Conference Speakers
Recommended Sessions
- COPD Pathogenesis
- Asthma and COPD
- Chronic Obstructive Pulmonary Disease
- Co-Morbidities of COPD
- COPD and Cardiovascular Diseases
- COPD Complications
- COPD Exacerbations
- COPD Therapeutics
- COPD: Sign and Symptoms
- Epidemiology of COPD
- Genetic risk factor of COPD
- Lung cancer
- Pathophysiology of COPD
- Pulmonary Hypertension
- Types of COPD
Related Journals
Are you interested in
- Advancements in Pulmonary Diagnostics - Respiratory 2024 (France)
- Asthma - Tuberculosis-2024 (France)
- Atelectasis and Pneumothorax - Tuberculosis-2024 (France)
- Cardio Pulmonary Disorders - Respiratory 2024 (France)
- Cardiopulmonary Disease - Tuberculosis-2024 (France)
- Chronic Obstructive Pulmonary Disease - Respiratory 2024 (France)
- Chronic Obstructive Pulmonary Disease (COPD) - Tuberculosis-2024 (France)
- Climate Change and Respiratory Diseases - Tuberculosis-2024 (France)
- COVID-19 and Asthma - Respiratory 2024 (France)
- COVID-19 and Respiratory System - Respiratory 2024 (France)
- Epidemiology of TB Disease - Tuberculosis-2024 (France)
- Gastroesophageal reflux disease (GERD) - Tuberculosis-2024 (France)
- Idiopathic Pulmonary Fibrosis - Respiratory 2024 (France)
- Interstitial Lung Disease - Respiratory 2024 (France)
- Latent TB Infection and Active TB Disease - Tuberculosis-2024 (France)
- Lung Cancer - Respiratory 2024 (France)
- Lung Cancer: Screening, Diagnosis & Treatment - Tuberculosis-2024 (France)
- Lung Function in Men with and without HIV - Tuberculosis-2024 (France)
- Lung Infection - Tuberculosis-2024 (France)
- Lung Transplantation - Respiratory 2024 (France)
- Multidrug-resistant TB - Tuberculosis-2024 (France)
- Mycobacterial Infections - Tuberculosis-2024 (France)
- Obstructive Sleep Apnea - Respiratory 2024 (France)
- Occupational Lung Diseases - Respiratory 2024 (France)
- Palliative Care for Advanced Lung Cancer - Tuberculosis-2024 (France)
- Pneumonia - Respiratory 2024 (France)
- Pulmonary Complications of Endocrine Diseases - Tuberculosis-2024 (France)
- Pulmonary Diseases and Therapeutics - Tuberculosis-2024 (France)
- Pulmonary diseases: Treatment, Diagnosis and therapies - Respiratory 2024 (France)
- Pulmonary Edema - Tuberculosis-2024 (France)
- Pulmonary Hypertension - Respiratory 2024 (France)
- Pulmonary Rehabilitation - Respiratory 2024 (France)
- TB Clinical Trials - Tuberculosis-2024 (France)
- TB Diagnosis, Prevention & Treatment - Tuberculosis-2024 (France)
- TB Vaccines - Tuberculosis-2024 (France)
- TB-HIV Co-infections - Tuberculosis-2024 (France)
- Tuberculosis - Respiratory 2024 (France)
- Zoonotic TB - Tuberculosis-2024 (France)